| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/28/2013 | WO2013041038A1 Pyridine compounds as inhibitors of kinase |
| 03/28/2013 | WO2013041014A1 Platinum compound having amino- or alkylamino-containing succinic acid derivatives as leaving group, preparation method therefor, and use thereof |
| 03/28/2013 | WO2013040944A1 Polyoxyethylene sorbitan monolaurate iodine complex |
| 03/28/2013 | WO2013040873A1 Sustained and controlled release of micro-granule formulation for treating intestinal disease and preparation method thereof |
| 03/28/2013 | WO2013040863A1 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors |
| 03/28/2013 | WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | WO2013040790A1 Substituted pyrimidines |
| 03/28/2013 | WO2013040789A1 Substituted pyrimidines |
| 03/28/2013 | WO2013040712A1 Composition comprising ku ding cha and ginseng for managing blood glucose levels |
| 03/28/2013 | WO2013040669A1 Compounds of the family of pterocarpan quinones, method for producing same, pharmaceutical composition, uses thereof and therapeutic method |
| 03/28/2013 | WO2013040647A1 Novel antimicrobial compounds |
| 03/28/2013 | WO2013016720A3 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases |
| 03/28/2013 | WO2013016580A3 Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer |
| 03/28/2013 | WO2013016315A8 Methods for treating niemann-pick type c disease |
| 03/28/2013 | WO2013016193A3 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 03/28/2013 | WO2013013657A8 Compressed solid pharmaceutical composition comprising amorphous particulate valsartan as the active ingredient |
| 03/28/2013 | WO2013012915A9 Heterocyclic compounds and uses thereof |
| 03/28/2013 | WO2013010218A9 Inhibition of clathrin |
| 03/28/2013 | WO2013010034A3 Methods for treating inflammation and hypertension with gamma-ketoaldehyde skavengers |
| 03/28/2013 | WO2013007447A3 Edible composition |
| 03/28/2013 | WO2013003465A9 Methods and compositions for treating skin |
| 03/28/2013 | WO2012177684A9 Use of caspase 3 activity and its inhibitors |
| 03/28/2013 | WO2012177075A3 Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections |
| 03/28/2013 | WO2012175587A3 Crystalline cefoperazone intermediate, process for its preparation and pharmaceutical use thereof |
| 03/28/2013 | WO2012173521A3 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
| 03/28/2013 | WO2012173448A3 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases |
| 03/28/2013 | WO2012173442A9 Composition containing bee venom phospholipase as an active ingredient treating prion disease |
| 03/28/2013 | WO2012173410A3 Novel c-aryl ansa sglt2 inhibitors |
| 03/28/2013 | WO2012172566A3 Novel sglt inhibitors |
| 03/28/2013 | WO2012172562A3 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation |
| 03/28/2013 | WO2012172438A3 Compositions and methods for modulating a kinase |
| 03/28/2013 | WO2012169785A3 Symmetrically structured quinazoline derivatives |
| 03/28/2013 | WO2012168949A3 A process for preparation of nevirapine |
| 03/28/2013 | WO2012168948A3 Process for febuxostat |
| 03/28/2013 | WO2012166891A3 Mu-opioid receptor binding compounds |
| 03/28/2013 | WO2012166463A3 Aminooxazole inhibitors of cyclin dependent kinases |
| 03/28/2013 | WO2012165914A3 Novel diphenylmethane derivatives as sglt2 inhibitors |
| 03/28/2013 | WO2012165854A3 Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes |
| 03/28/2013 | WO2012165810A3 Pharmaceutical composition containing wogonin as an active ingredient for preventing or treating asthma |
| 03/28/2013 | WO2012162580A3 Anti-viral compounds |
| 03/28/2013 | WO2012162513A3 Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase i inhibitors |
| 03/28/2013 | WO2012160576A3 A process for preparation of meropenem |
| 03/28/2013 | WO2012159120A3 Gene therapy based strategy for treating hiv |
| 03/28/2013 | WO2012155066A3 Spiro-oxindole mdm2 antagonists |
| 03/28/2013 | WO2012151512A3 Bromodomain inhibitors and uses thereof |
| 03/28/2013 | WO2012146736A8 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |
| 03/28/2013 | WO2012136873A8 Triazine derivatives and their uses as trpv1 inhibitors |
| 03/28/2013 | WO2012057212A9 Percutaneous absorption type formulation |
| 03/28/2013 | WO2012052491A3 1-(heterocyclic carbonyl)-2-substituted pyrrolidines and their use as fungicides |
| 03/28/2013 | WO2012041292A3 Compounds for diagnosing neurodegenerative diseases at the retina |
| 03/28/2013 | WO2012021991A8 Anti-viral carbamimidothioic acid esters |
| 03/28/2013 | WO2012019139A9 Combined drug delivery methods and apparatus |
| 03/28/2013 | WO2011146879A3 Methods and compositions related to modulating autophagy |
| 03/28/2013 | WO2011103920A3 Pharmaceutical or neutraceutical formulation |
| 03/28/2013 | WO2011039369A3 Amorphous forms of a 2-amino-4-(4-fluorobenzylamino)phenylcarbamate derivative |
| 03/28/2013 | WO2011006935A3 Tetrazole derivatives |
| 03/28/2013 | WO2010130779A3 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseases |
| 03/28/2013 | WO2008076278A8 Methods of cancer treatment with igf1r inhibitors |
| 03/28/2013 | US20130079767 Embolization |
| 03/28/2013 | US20130079537 Ferric organic compounds, uses thereof and methods of making same |
| 03/28/2013 | US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells" |
| 03/28/2013 | US20130079417 Highly Selective 5-HT(2C) Receptor Agonists That Show Anti-Psychotic Effects with Antagonist Activity at the 5-HT(2B) Receptor |
| 03/28/2013 | US20130079416 Homeopathic medicament comprising phenacetin for the treatment of cancer |
| 03/28/2013 | US20130079415 Compositions comprising amphetamin and lisdexamfetamine |
| 03/28/2013 | US20130079414 Enhanced bimatoprost ophthalmic solution |
| 03/28/2013 | US20130079412 Branched 3-phenylpropionic acid derivatives and their use |
| 03/28/2013 | US20130079411 Method for preventing or treating a disease, disorder or condition induced by retina ischemia |
| 03/28/2013 | US20130079409 Stable pharmaceutical composition and methods of using same |
| 03/28/2013 | US20130079406 Therapeutic compositions |
| 03/28/2013 | US20130079403 Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| 03/28/2013 | US20130079402 Use of at Least One Dialkyl Thiosulfonate or Thiosulfinate for Reducing the Number of Apicomplexa in an Animal |
| 03/28/2013 | US20130079401 Novel use of isothiocyanates for treating cancer |
| 03/28/2013 | US20130079398 Pharmaceutical composition for preventing or treating nervous system disorders comprising sulfuretin or pharmaceutically acceptable salt thereof |
| 03/28/2013 | US20130079397 Process for production of optically active amine derivatives |
| 03/28/2013 | US20130079395 Novel process |
| 03/28/2013 | US20130079391 Lipase inhibiting composition |
| 03/28/2013 | US20130079390 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
| 03/28/2013 | US20130079387 Antisense oligonucleotide modulation of raf gene expression |
| 03/28/2013 | US20130079385 USP47 Inhibtors and Methods to Induce Apoptosis |
| 03/28/2013 | US20130079384 Means and Methods for Determining Risk of Cardiovascular Disease |
| 03/28/2013 | US20130079380 Method and Composition for Administering Bioactive Compounds Derived From Morinda Citrifolia |
| 03/28/2013 | US20130079379 Gel compositions of oxymetazoline and methods of use |
| 03/28/2013 | US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079375 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 03/28/2013 | US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079372 Substituted Phenylcarbamoyl Alkylamino Arene Compounds and N,N'-BIS-Arylurea Compounds |
| 03/28/2013 | US20130079371 Bioadhesive Compositions of Local Anaesthetics |
| 03/28/2013 | US20130079370 Method for the Inhibition of Deubiquitinating Activity |
| 03/28/2013 | US20130079369 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| 03/28/2013 | US20130079366 Benzisoxazoles and Azabenzisoxazoles as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 03/28/2013 | US20130079365 New bicyclic dihydroquinoline-2-one derivatives |
| 03/28/2013 | US20130079364 Peripheral Opioid Agonists and Peripheral Opioid Antagonists |
| 03/28/2013 | US20130079356 Method for the treatment of premenstrual and other female sexual disorders |
| 03/28/2013 | US20130079355 Use of Flibanserin in the Treatment of Obesity |
| 03/28/2013 | US20130079354 Pyridyl derivatives and their use as therapeutic agents |
| 03/28/2013 | US20130079353 Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases |
| 03/28/2013 | US20130079351 2-acylaminothiazole derivative or salt thereof |
| 03/28/2013 | US20130079347 Novel sulfonylpyrroles |
| 03/28/2013 | US20130079346 Benzoic acid derivatives |
| 03/28/2013 | US20130079345 Pharmaceutically active disubstituted triazine derivatives |